8-K current report · filed Aug 5, 2026

Solventum (SOLV) 8-K Current Report: August 5, 2026

Item 2.02Item EX-99.1SOLV overview

Short answer

Solventum (SOLV) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Solventum reported second-quarter 2026 financial results on August 5, 2026.

Solventum 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Solventum reported second-quarter 2026 financial results on August 5, 2026
  • Exhibit 99.1 contains the quarter’s financial results and management commentary for investor review

Item EX-99.1 · Exhibit EX-99.1

  • Q2 sales $2.209B, up 2.2% reported and 9.5% organically, with growth across every reportable segment
  • Adjusted EPS $2.55, up 50.9%, but GAAP operating margin fell 170 bps to 8.2% amid legal and separation costs
  • Health Information Systems separation planned, reshaping Solventum toward a focused MedTech portfolio while creating execution and transaction risk
  • 2026 guidance raised: organic growth 2.5%-3.0%, adjusted EPS $7.10-$7.20, free cash flow $200M-$300M
  • Q2 free cash flow $144M, supported by tax-payment timing and insurance proceeds, while six-month free cash flow remained negative at $129M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Solventum 8-K filings

Get the next SOLV 8-K as it lands

Follow SOLV for push alerts, or ask the research agent what this filing means.